122 related articles for article (PubMed ID: 7627849)
1. Over-expression of metallothionein and drug-resistance in bladder cancer.
Saika T; Tsushima T; Ochi J; Akebi N; Nasu Y; Matsumura Y; Ohmori H
Int J Urol; 1994 Jun; 1(2):135-9. PubMed ID: 7627849
[TBL] [Abstract][Full Text] [Related]
2. [Immunological study of induction of metallothionein in bladder cancers].
Saika T
Nihon Hinyokika Gakkai Zasshi; 1992 May; 83(5):643-9. PubMed ID: 1495202
[TBL] [Abstract][Full Text] [Related]
3. [Histopathological study of metallothionein in bladder cancer and renal cell carcinoma].
Saika T; Tsushima T; Nasu Y; Akebi N; Noda M; Kobashi K; Matsumura Y; Ohmori H
Nihon Hinyokika Gakkai Zasshi; 1992 May; 83(5):636-42. PubMed ID: 1495201
[TBL] [Abstract][Full Text] [Related]
4. Concurrent expressions of metallothionein, glutathione S-transferase-pi, and P-glycoprotein in colorectal cancers.
Sutoh I; Kohno H; Nakashima Y; Hishikawa Y; Tabara H; Tachibana M; Kubota H; Nagasue N
Dis Colon Rectum; 2000 Feb; 43(2):221-32. PubMed ID: 10696897
[TBL] [Abstract][Full Text] [Related]
5. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.
Lee FY; Sciandra J; Siemann DW
Biochem Pharmacol; 1989 Nov; 38(21):3697-705. PubMed ID: 2574574
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of a cisplatin-resistant human neuroblastoma cell line.
Yasuno T; Matsumura T; Shikata T; Inazawa J; Sakabe T; Tsuchida S; Takahata T; Miyairi S; Naganuma A; Sawada T
Anticancer Res; 1999; 19(5B):4049-57. PubMed ID: 10628353
[TBL] [Abstract][Full Text] [Related]
7. Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.
Lai GM; Moscow JA; Alvarez MG; Fojo AT; Bates SE
Int J Cancer; 1991 Nov; 49(5):688-95. PubMed ID: 1682279
[TBL] [Abstract][Full Text] [Related]
8. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin.
Kasahara K; Fujiwara Y; Nishio K; Ohmori T; Sugimoto Y; Komiya K; Matsuda T; Saijo N
Cancer Res; 1991 Jun; 51(12):3237-42. PubMed ID: 1645616
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
Singh SV; Xu BH; Jani JP; Emerson EO; Backes MG; Rihn C; Scalamogna D; Stemmler N; Specht S; Blanock K
Int J Cancer; 1995 May; 61(3):431-6. PubMed ID: 7729958
[TBL] [Abstract][Full Text] [Related]
10. [Establishment and characterization of a cis-diamminedichloro platinum-resistant human bladder cancer cell line].
Ochi J
Nihon Hinyokika Gakkai Zasshi; 1991 Jul; 82(7):1045-52. PubMed ID: 1895616
[TBL] [Abstract][Full Text] [Related]
11. Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy.
Kawai H; Kiura K; Tabata M; Yoshino T; Takata I; Hiraki A; Chikamori K; Ueoka H; Tanimoto M; Harada M
Lung Cancer; 2002 Mar; 35(3):305-14. PubMed ID: 11844606
[TBL] [Abstract][Full Text] [Related]
12. [A study on the relationship between sensitivity to CDDP and inducibility of metallothionein and glutathione of genitourinary tumors].
Yamagata K; Kondo Y
Nihon Hinyokika Gakkai Zasshi; 1995 Oct; 86(10):1575-82. PubMed ID: 7474609
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein in bladder cancer: correlation of overexpression with poor outcome after chemotherapy.
Wülfing C; van Ahlen H; Eltze E; Piechota H; Hertle L; Schmid KW
World J Urol; 2007 Apr; 25(2):199-205. PubMed ID: 17253087
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of testis tumour cells to chemotherapeutic drugs: role of detoxifying pathways.
Masters JR; Thomas R; Hall AG; Hogarth L; Matheson EC; Cattan AR; Lohrer H
Eur J Cancer; 1996 Jun; 32A(7):1248-53. PubMed ID: 8758261
[TBL] [Abstract][Full Text] [Related]
15. Distinct P-glycoprotein expression in two subclones simultaneously selected from a human colon carcinoma cell line by cis-diamminedichloroplatinum (II).
Yang LY; Trujillo JM; Siciliano MJ; Kido Y; Siddik ZH; Su YZ
Int J Cancer; 1993 Feb; 53(3):478-85. PubMed ID: 8094074
[TBL] [Abstract][Full Text] [Related]
16. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein, glutathione and glutathione S-transferase increase in a colon carcinoma cell line by colchicine.
Ruiz-Gómez MJ; Souviron A; Martínez-Morillo M; Gil L
J Physiol Biochem; 2000 Dec; 56(4):307-12. PubMed ID: 11321524
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer: pretreatment drug resistance parameters (GSH-system, ATase, P-glycoprotein) in tumor tissue and their correlation with clinical and prognostic characteristics.
Buser K; Joncourt F; Altermatt HJ; Bacchi M; Oberli A; Cerny T
Ann Oncol; 1997 Apr; 8(4):335-41. PubMed ID: 9209662
[TBL] [Abstract][Full Text] [Related]
20. Carbon monoxide sensitizes cisplatin-resistant ovarian cancer cell lines toward cisplatin via attenuation of levels of glutathione and nuclear metallothionein.
Kawahara B; Ramadoss S; Chaudhuri G; Janzen C; Sen S; Mascharak PK
J Inorg Biochem; 2019 Feb; 191():29-39. PubMed ID: 30458366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
